Ivonescimab in the Treatment of Multiple Advanced Tumors | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Ivonescimab in the Treatment of Multiple Advanced Tumors	Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Male Urogenital Diseases, Myosarcoma, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Adipose Tissue, Neoplasms, Connective and Soft Tissue, Neoplasms, Ductal, Lobular, and Medullary, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Urogenital Diseases, Urogenital Neoplasms, adenocarcinoma, angiomyolipoma, basal cell carcinoma, basal cell neoplasm, benign urinary system neoplasm, bladder urachal carcinoma, carcinoma, epithelial neoplasm, extramammary Paget disease, kidney angiomyolipoma, kidney cancer, kidney disorder, male reproductive organ cancer, male reproductive system disorder, myomatous neoplasm, neoplasm, neoplasm with perivascular epithelioid cell differentiation, neuroendocrine carcinoma, neuroendocrine neoplasm, paraganglioma, penile cancer, penile disorder, penile neoplasm, pheochromocytoma, pheochromocytoma-paraganglioma, primitive neuroectodermal tumor, prostate cancer, prostate disorder, rhabdomyosarcoma, sarcoma, sarcomatoid carcinoma, transitional cell carcinoma, urinary system disorder, urothelial carcinoma	Recruiting	Phase 2	2025-08-24		NCT06683846

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Fudan University	653

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Fudan University Cancer Hospital	Shanghai	China	5